Dr Sulaiman Al Habib Medical vs HCA Healthcare: Fair Value & Quality
Both stocks run through our valuation models. Here is how Dr Sulaiman Al Habib Medical (4013) and HCA Healthcare (HCA) compare, as of Sep 5, 2026.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
HCA Healthcare leads: 5 to 8 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
What the models say
How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.
▲above the price, more than 15% above ●close to the price, 85% to 115% of the price ▼below the price, more than 15% below
| Model family | Dr Sulaiman Al Habib MedicalPrice SAR 230 | HCA HealthcarePrice $409 |
|---|---|---|
| DCF Models | ▼-55%below the priceSAR 103 | ▲+33%above the price$546 |
| Earnings-Based | ▼-53%below the priceSAR 109 | ▼-29%below the price$289 |
| Dividend Discount | ▼-64%below the priceSAR 83.58 | ▼-87%below the price$53.85 |
| Multiples | ▼-51%below the priceSAR 112 | ▲+64%above the price$673 |
| Asset-Based | ▼-93%below the priceSAR 15.13 | n/a |
| Growth DCF | n/a | ▲+32%above the price$540 |
| Economic Profit | ▼-69%below the priceSAR 71.76 | ●+2%close to the price$419 |
| Growth Earnings | ▼-28%below the priceSAR 165 | ▲+24%above the price$506 |
| Minimum | ▼-93%below the priceSAR 15.13 | ▼-87%below the price$53.85 |
| Maximum | ▼-28%below the priceSAR 165 | ▲+64%above the price$673 |
| Median | ▼-55%below the priceSAR 103 | ▲+24%above the price$506 |
| Geometric mean | ▼-66%below the priceSAR 78.79 | ●-14%close to the price$351 |
Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.
Dr Sulaiman Al Habib Medical: 21 of 22 models see the stock below the current price.
HCA Healthcare: 6 of 23 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Dr Sulaiman Al Habib Medical · Health Care
HCA Healthcare · Health Care
Bottom line
As of Sep 5, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Dr Sulaiman Al Habib Medical trades at SAR 230 versus a fair value of SAR 112 (-51%), while HCA Healthcare trades at $409 versus $548 (+34%).
HCA Healthcare has the higher quality score (71/100).
See the full analysis →More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Related to Dr Sulaiman Al Habib Medical
Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupMerck & Company vs UnitedHealth GroupSee the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.